Coherus BioSciences, Inc. a global biosciences company with late-stage medical products has announced its Annual Financial Results for FY-2014.
Total Revenues went to $6.5 million in 2014 4th quarter whether it was$1.2 million in the same quarter of 2013. Cash is $150.4 Million as per $39.6 million is 2013.
View full earnings release here.